|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Organogenesis Holdings insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Organogenesis Holdings insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-21-2022 Insider Buy |
Michael W. Katz >10% Owner |
$2.56
CAGR »
|
$15,390.00 6,000 shares |
8-12-2022 Insider Buy |
Michael Joseph Driscoll Director |
$4.80
CAGR »
|
$24,000.00 5,000 shares |
8-12-2022 Insider Buy |
Arthur S. Leibowitz Director |
$4.75
CAGR »
|
$14,265.00 3,000 shares |
5-16-2022 Insider Buy |
Michael W. Katz >10% Owner |
$6.03
CAGR »
|
$60,297.80 10,000 shares |
12-13-2021 Insider Buy |
Michael W. Katz >10% Owner |
$9.65
CAGR »
|
$4,825.00 500 shares |
12-3-2021 Insider Buy |
Michael W. Katz >10% Owner |
$9.57
CAGR »
|
$24,870.00 2,600 shares |
11-29-2021 Insider Buy |
Michael W. Katz >10% Owner |
$9.75
CAGR »
|
$9,750.00 1,000 shares |
11-26-2021 Insider Buy |
Michael W. Katz >10% Owner |
$9.79
CAGR »
|
$19,570.00 2,000 shares |
11-18-2021 Insider Buy |
Glenn H. Nussdorf Director and >10% Owner |
$9.93
CAGR »
|
$248,250.00 25,000 shares |
11-18-2021 Insider Buy |
2016 Organo 10-year Grat U/A/D September 30, 2016 GN >10% Owner |
$9.93
CAGR »
|
$248,250.00 25,000 shares |
11-17-2021 Insider Buy |
Michael W. Katz >10% Owner |
$11.11
CAGR »
|
$55,550.00 5,000 shares |
8-17-2021 Insider Buy |
Michael W. Katz >10% Owner |
$13.55
CAGR »
|
$162,600.00 12,000 shares |
12-2-2020 Insider Buy |
Wayne D. Mackie Director |
$5.26
CAGR »
|
$203,614.60 38,710 shares |
11-24-2020 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$4.99
CAGR »
|
$14,170.62 2,839 shares |
11-17-2020 Insider Buy |
Glenn H. Nussdorf Director and >10% Owner |
$3.25
CAGR »
|
$2,707,747.25 833,153 shares |
11-17-2020 Insider Buy |
Alan A. Ades Director and >10% Owner |
$3.25
CAGR »
|
$2,707,747.25 833,153 shares |
11-19-2020 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$3.29
CAGR »
|
$14,500,671.64 4,404,162 shares |
11-17-2020 Insider Buy |
Michael W. Katz >10% Owner |
$3.25
CAGR »
|
$67,694.25 20,829 shares |
11-17-2020 Insider Buy |
Arthur S. Leibowitz Director |
$3.25
CAGR »
|
$22,564.75 6,943 shares |
11-17-2020 Insider Buy |
Wayne D. Mackie Director |
$3.25
CAGR »
|
$138,859.50 42,726 shares |
3-16-2020 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$3.98
CAGR »
|
$2,160,956.66 542,349 shares |
11-26-2019 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$5.00
CAGR »
|
$30,000,000.00 6,000,000 shares |
9-13-2019 Insider Buy |
Wayne D. Mackie Director |
$6.13
CAGR »
|
$30,569.66 4,990 shares |
9-13-2019 Insider Buy |
Michael W. Katz >10% Owner |
$6.00
CAGR »
|
$21,618.00 3,603 shares |
9-12-2019 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$5.99
CAGR »
|
$5,155,772.37 860,900 shares |
9-11-2019 Insider Buy |
Wayne D. Mackie Director |
$5.30
CAGR »
|
$69,017.27 13,010 shares |
9-10-2019 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$5.18
CAGR »
|
$2,782,529.30 537,000 shares |
9-6-2019 Insider Buy |
Alan A. Ades Director and >10% Owner |
$5.03
CAGR »
|
$50,274.00 10,000 shares |
9-6-2019 Insider Buy |
Glenn H. Nussdorf Director and >10% Owner |
$5.03
CAGR »
|
$50,274.00 10,000 shares |
9-4-2019 Insider Buy |
Michael W. Katz >10% Owner |
$4.50
CAGR »
|
$44,975.00 10,000 shares |
9-4-2019 Insider Buy |
Wayne D. Mackie Director |
$4.47
CAGR »
|
$366,210.60 82,000 shares |
9-3-2019 Insider Buy |
Arthur S. Leibowitz Director |
$4.20
CAGR »
|
$21,000.00 5,000 shares |
9-5-2019 Insider Buy |
Alan A. Ades Director and >10% Owner |
$4.50
CAGR »
|
$473,209.00 105,100 shares |
9-5-2019 Insider Buy |
Glenn H. Nussdorf Director and >10% Owner |
$4.50
CAGR »
|
$473,209.00 105,100 shares |
9-5-2019 Insider Buy |
Avista Capital Managing Member IV, LLC
|
$4.84
CAGR »
|
$2,797,550.56 577,600 shares |
Also See: Institutional Holders of ORGO
Also See: SEC filings
Below we present the annualized performance delivered by Organogenesis Holdings stock since 11-21-2022 (the date of the most recent
insider purchase). The performance of the investment from the time Organogenesis Holdings insider buying occurred is the ultimate
test of whether insiders were right about ORGO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/22/2022 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$2.71 |
|
End price/share: |
$2.35 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-13.28% |
|
Average Annual Total Return: |
-9.52% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,671.66 |
|
Years: |
1.42 |
|
Organogenesis Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Organogenesis Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ORGO
|
|